MicroPulse – Not Just for End Stage Glaucoma Patients

Traditional cyclophotocoagulation has been deeply ingrained as a procedure that is only for severe, end stage glaucoma in patients with poor vision. However, MicroPulse transscleral cyclophotocoagulation (MP-TSCPC; Iridex Corporation) is a therapy that has the benefits of traditional CPC without the destruction and inflammation that often accompanies it. Unlike traditional CPC performed with a continuous wave diode laser, the MicroPulse platform separates the laser beam into short bursts that allow for a cooling or rest period between pulses. This makes the procedure much safer and less

Full Story →